Digital Embracing AI Technology Will Be Key to the Future of UK Life... From programmers to pilots, seemingly all industries are being forced to consider how AI might revolutionise their work.
Digital What’s next for clinical data management? The life sciences industry has seen its share of headwinds and tailwinds in recent years.
Digital Short-term crucial to future of AI drug discovery One of the lead prospects in a new generation of AI-developed drug candidates struggled in late-stage trials.
Digital The benefits of adopting a truly digital mindset for pharmac... Historically, the pharmaceutical industry has been in the laggard phase when it comes to digital adoption.
Digital The precision element at the heart of digital transformation On the final day of Reuters Pharma Barcelona back in March, web editor Nicole Raleigh sat down with Graphite Digital’s CEO, Rob Verheul.
Digital AI in drug development: A reality check In this episode of the pharmaphorum podcast, editor-in-chief Jonah Comstock catches up with Adityo Prakash, CEO of Verseon, to shed some light on what the potential of AI in drug discovery
News Merck rare tumour drug Ezmekly backed for NHS use Merck's drug for tumours associated with rare disease neurofibromatosis type 1, Ezmekly, has been cleared for NHS use in children as young as two.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.